Stock HCG HEALTHCARE GLOBAL ENTERPRISES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials HealthCare Global Enterprises Limited Bombay S.E.

Equities

HCG

INE075I01017

Healthcare Facilities & Services

Delayed Bombay S.E.
Other stock markets
 10:43:54 16/07/2024 am IST 		5-day change 1st Jan Change
363.3 INR +1.16% Intraday chart for HealthCare Global Enterprises Limited -2.45% -0.53%
28/06 HealthCare Global Enterprises to Acquire Vizag Hospital MT
28/06 HealthCare Global Enterprises Limited entered into share purchase agreement to acquire 51% stake in Vizag Hospital and Cancer Research Centre Private Limited for INR 2.1 billion. CI

Valuation

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,342 6,570 23,881 37,519 36,511 50,144 - -
Enterprise Value (EV) 1 24,802 12,483 27,604 44,350 43,069 56,751 58,524 56,843
P/E ratio -78 x -6.15 x -11.2 x 68 x 125 x 98.5 x 56 x 36.4 x
Yield - - - - - - - -
Capitalization / Revenue 1.98 x 0.6 x 2.36 x 2.68 x 2.15 x 2.47 x 2.28 x 2.03 x
EV / Revenue 2.53 x 1.14 x 2.72 x 3.17 x 2.54 x 2.97 x 2.67 x 2.31 x
EV / EBITDA 19.8 x 7.81 x 21.8 x 18.6 x 14.4 x 17.2 x 14.6 x 12 x
EV / FCF -27.5 x 55.9 x 32.4 x 29.8 x 36.4 x 57.4 x 29.6 x 24 x
FCF Yield -3.64% 1.79% 3.08% 3.36% 2.75% 1.74% 3.38% 4.16%
Price to Book 3.54 x 1.72 x 3.43 x 4.31 x 4.24 x 5.7 x 5.51 x 4.79 x
Nbr of stocks (in thousands) 87,919 88,666 1,25,359 1,39,012 1,39,116 1,39,348 - -
Reference price 2 220.0 74.10 190.5 269.9 262.4 359.8 359.8 359.8
Announcement Date 23/05/19 28/07/20 17/06/21 26/05/22 25/05/23 29/05/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 9,787 10,923 10,134 13,978 16,944 19,079 21,960 24,654
EBITDA 1 1,252 1,599 1,266 2,380 2,987 3,296 4,006 4,741
EBIT 1 401 114.2 -326.3 797 1,352 1,552 2,126 2,712
Operating Margin 4.1% 1.05% -3.22% 5.7% 7.98% 8.14% 9.68% 11%
Earnings before Tax (EBT) 1 -333.8 -1,193 -2,287 877.7 448.7 677.2 1,214 1,849
Net income 1 -248 -1,067 -1,935 537.3 293.4 481.4 843.3 1,334
Net margin -2.53% -9.77% -19.09% 3.84% 1.73% 2.52% 3.84% 5.41%
EPS 2 -2.820 -12.05 -17.02 3.970 2.100 3.430 6.428 9.892
Free Cash Flow 1 -902.8 223.3 851 1,489 1,184 989 1,976 2,366
FCF margin -9.22% 2.04% 8.4% 10.65% 6.98% 5.18% 9% 9.6%
FCF Conversion (EBITDA) - 13.97% 67.22% 62.56% 39.62% 30.01% 49.32% 49.9%
FCF Conversion (Net income) - - - 277.11% 403.37% 205.44% 234.25% 177.39%
Dividend per Share 2 - - - - - - - -
Announcement Date 23/05/19 28/07/20 17/06/21 26/05/22 25/05/23 29/05/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Marzo 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,740 2,980 3,231 3,520 3,581 3,646 4,080 4,200 4,247 4,417 4,607 4,799 4,886 4,961 5,170
EBITDA 1 378.4 393.6 512.3 617.4 618.6 631.5 721.6 746.9 755.1 763.2 743.1 835.2 873 872 925.8
EBIT 1 -39.9 9.8 134.5 237.2 204.8 220.5 324.9 338.6 347.4 341.2 333 479.6 466.6 458.6 453.8
Operating Margin -1.46% 0.33% 4.16% 6.74% 5.72% 6.05% 7.96% 8.06% 8.18% 7.72% 7.23% 9.99% 9.55% 9.24% 8.78%
Earnings before Tax (EBT) 1 -353.9 -1,044 -89.2 1,419 - - 104.2 100.2 - 131.3 105.2 293 170 216 219
Net income 1 -347.3 -1,022 -95.7 1,031 - 59.9 60.5 73.8 75.4 83.7 76.1 183.8 157.8 147 200.7
Net margin -12.67% -34.28% -2.96% 29.29% - 1.64% 1.48% 1.76% 1.78% 1.89% 1.65% 3.83% 3.23% 2.96% 3.88%
EPS 2 -2.330 -8.140 -0.7600 7.690 -3.550 - 0.4300 - 0.5400 0.6000 0.5400 2.070 1.940 1.425 1.675
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/02/21 17/06/21 12/08/21 11/11/21 10/02/22 26/05/22 10/08/22 10/11/22 09/02/23 25/05/23 10/08/23 - - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 5,460 5,913 3,723 6,830 6,558 9,695 8,380 6,698
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 4.362 x 3.698 x 2.941 x 2.87 x 2.195 x 2.942 x 2.092 x 1.413 x
Free Cash Flow 1 -903 223 851 1,489 1,184 989 1,976 2,366
ROE (net income / shareholders' equity) -4.67% -24.9% -19.1% 6.86% 3.39% 5.71% 9.14% 11.7%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 62.10 43.00 55.60 62.60 61.90 59.30 65.40 75.10
Cash Flow per Share - - - - - - - -
Capex 1 1,888 1,078 354 712 1,332 1,857 2,318 1,536
Capex / Sales 19.29% 9.87% 3.5% 5.1% 7.86% 9.73% 10.55% 6.23%
Announcement Date 23/05/19 28/07/20 17/06/21 26/05/22 25/05/23 29/05/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for HealthCare Global Enterprises Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
359.8 INR
Average target price
432.1 INR
Spread / Average Target
+20.08%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+17.11% 83.02B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-25.70% 73.65B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
0.00% 26.5B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+2.67% 17.72B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-8.71% 17.49B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+4.87% 16.06B
NATERA, INC. Stock Natera, Inc.
+79.85% 13.83B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+73.90% 12.84B
PURE HEALTH HOLDING Stock Pure Health Holding
-26.14% 12.73B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. HCG Stock
  4. HCG Stock
  5. Financials HealthCare Global Enterprises Limited